News
Celldex advances cancer drug candidate
Mon, 10/29/2012 - 12:00am
Celldex Therapeutics, Inc. (NASDAQ: CLDX) has announced positive Phase 1 trial results for its experimental vaccine for solid tumors, in combination with two approved drugs.
